CD19 and pulmonary arterial hypertension: Comparison of the percentage of CD19+CTLA4+ B lymphocytes in selected types of PAH and in the control group revealed a significantly higher percentage of these lymphocytes in the iPAH group than in the CTD-PAH and CHD-PAH groups (p < 0.05).